Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Pharmaceuticals & Biotech
/
Fortress Biotech
FBIO
Fortress Biotech
FDA Approval Will Open $1 Billion Dermatology Market
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
06 Jul 25
Updated
24 Jul 25
7
Set Fair Value
1
votes
Share
AnalystConsensusTarget
's Fair Value
US$10.00
81.2% undervalued
intrinsic discount
24 Jul
US$1.88
Loading
1Y
4.4%
7D
-5.1%
Author's Valuation
US$10.0
81.2% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$10.0
81.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-104m
345m
2014
2017
2020
2023
2025
2026
2028
Revenue US$345.4m
Earnings US$36.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
42.44%
Biotech revenue growth rate
10.61%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.23%
Calculation
US$36.40m
Earnings '28
x
22.46x
PE Ratio '28
=
US$817.53m
Market Cap '28
US$817.53m
Market Cap '28
/
64.39m
No. shares '28
=
US$12.70
Share Price '28
US$12.70
Share Price '28
Discounted to 2025 @ 8.28% p.a.
=
US$10.00
Fair Value '25